Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
about
The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cellsExpression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A functionRole of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammationContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.Interleukin-1 gene expression in rabbit vascular tissue in vivo.Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall.Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and miceExpression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions.Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine releaseIncreased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease.Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.Interleukin 1 inhibits contraction of vascular smooth muscle.Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cellsEndovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1Induction of aneurysms in the rat by a stenosing cotton ligature around the inter-renal aorta.Inflammation in atherosclerosis.Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.Long-term reversal of diabetes by the injection of immunoprotected islets.Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma.Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts.Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feedingInterleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells.Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase.Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.Tissue stroma as a regulator of leukocyte recruitment in inflammation.Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process.Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.Interleukin-1: therapeutic potential for solid tumors.Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release.
P2860
Q22254013-83019C4A-6682-47E8-82A0-C11A73B5AC85Q24563622-F77A2A26-E099-402F-BA61-057F1D154605Q28544866-27F40A1C-1DF8-418F-BB5F-7CA8F7EB9A17Q30318502-9E87294C-6033-4FC3-9FC0-F85992F4B493Q30319434-3292216F-ED92-48FC-BE09-768B85EE8650Q33355903-F7EE8B98-70AD-4FD7-ACC3-142230F23D65Q33528100-ABD3C22D-98CE-40F4-AEEF-0D7E52E40B99Q33567932-CF4A311F-6BB7-440B-99DB-94E3E0653D8DQ34117664-5FCEA2D2-F146-4423-9054-0B244A42FF17Q34189933-CEB42B0D-E9A6-4BAC-8747-A6A153E91D69Q34244878-367AC200-FD91-4DC2-A2E3-B97598BDCB65Q34255810-24F53F6C-2EF7-4D26-AFDC-9900FD538401Q34327535-89A22814-E866-40D6-9FB5-8A61BC7BE301Q34347211-FA58EA19-4D6E-470E-B15F-5F1B8D4771DEQ34556829-AEDBF5FE-A4F3-4AF7-B190-0EEAC7571740Q34565083-9D266751-83DF-4368-8DF4-40E936BEB48FQ34570163-516B06B8-CBF3-4455-A55D-96AD8272D2EEQ35043172-23221D82-D1D4-434F-A1C8-86E1D409B2FCQ35309145-A7048388-A700-4509-A643-89CBFCF3CE19Q35809793-A02CF329-C0C8-406D-9169-D01B45C7A4FAQ35833262-BFC8A62C-C1DA-4F5D-8A9F-526054B8D1D4Q35871622-BDDC33A8-07C6-4ECE-895A-669F243E6B69Q36028219-21679E84-A8AB-46CF-BD65-510A4D732799Q36174933-24422F38-AB06-4CAD-9CD7-AB7B15F90F2DQ36352574-A22F2E91-D648-43DA-BFDA-D9BA9BBB85A5Q36378895-5AAD16F3-63FF-4AF2-935F-87FACBD6F15CQ36833376-64AE429C-4CD4-4A9D-AA2D-8460AF128BD2Q36922837-BBFCAA98-FE9E-487D-9487-E3AEA636FC6EQ37023342-FD9B1FF5-CE26-4EA1-8AC1-68A5BD9D55FAQ37141472-69FDB38E-A2FD-4C9B-A77F-41F86A1AC692Q37365521-613D2CE6-E10C-41D3-8D54-A66F25CD1D58Q37384330-7365A88B-5B98-46B4-9E9C-0810441FDC56Q37712586-689BE806-E07C-4739-B4BC-A16CC4290280Q37768849-EE5E93AC-8D4E-49F7-B42D-E0F55FCA3B27Q37974087-D4669E64-7A04-43EE-A169-980012FEB961Q38241516-304E0DFB-C292-4D9B-8E57-062D61B2555EQ38321993-5C26ACCB-B2D0-4EB6-B066-CCA0A24189E7Q39821499-632C9D04-8D1D-41C3-83C8-12818FA3A821Q40860960-791EEF73-9859-4FDE-A0DE-EF66D2D4D9EEQ40904439-A723D5CE-3003-447C-A8CB-069DFD915419
P2860
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
description
1986 nî lūn-bûn
@nan
1986 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@ast
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@en
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@nl
type
label
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@ast
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@en
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@nl
prefLabel
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@ast
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@en
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@nl
P2093
P2860
P356
P1476
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
@en
P2093
C A Dinarello
J M Ordovas
L K Birinyi
P2860
P304
P356
10.1172/JCI112732
P407
P577
1986-12-01T00:00:00Z